about
Oral pathology in inflammatory bowel disease[Methotrexate toxicity. Myths and facts].In vitro inhibition of HUVECs by low dose methotrexate - insights into oral adverse events.Cutaneous dermatomyositis: an updated review of treatment options and internal associations.Methotrexate-induced pneumonitis in Crohn's disease. Case report and review of the literatureOral manifestations of T-cell large granular lymphocytic leukemia: a case report.Atypical methotrexate ulcerative stomatitis with features of lymphoproliferative like disorder: Report of a rare ciprofloxacin-induced case and review of the literatureNon-healing tongue ulcer in a rheumatoid arthritis patient medicated with leflunomide. An adverse drug event?The use of methotrexate in dermatology: a review.Three decades of low-dose methotrexate in rheumatoid arthritis: can we predict toxicity?EBV-Positive B-Cell Proliferations of Varied Malignant Potential: 2015 SH/EAHP Workshop Report-Part 1.Investigating methotrexate toxicity within a randomized double-blinded, placebo-controlled trial: Rationale and design of the Cardiovascular Inflammation Reduction Trial-Adverse Events (CIRT-AE) Study.British Association of Dermatologists' guidelines for the safe and effective prescribing of methotrexate for skin disease 2016.Methotrexate-related lymphoproliferative disorder arising in the gingiva of a patient with rheumatoid arthritis.Oral Methotrexate-related Lymphoproliferative Disease Presenting with Severe Osteonecrosis of the Jaw: A Case Report and Literature Review.Impact of rheumatic diseases on oral health and quality of life.
P2860
Q26739055-F098329C-6942-434D-BDCB-D2EA269C4CE8Q30318490-EA52010B-CD77-4603-B502-BE7E22A02A34Q33661406-188BF995-1CF3-45BA-BA1C-F074BA258D89Q34349952-95C680B6-1F99-473E-A9CB-82FDEE130971Q36293824-D51B5409-D929-4978-904F-815C65607FD8Q37454745-AE0B22F8-A1F4-4E8E-9AEB-FB932774476AQ37491546-749DD9FC-A2C3-48DC-8D1B-F9BAACC21359Q37637240-B3DD6766-EE03-4D4B-B3C3-716537BDE1D7Q37981730-BA64B589-E246-4782-99E1-09DECEDD2E64Q38267703-549CE5A4-3C3F-4240-A67A-2CA62DECCA77Q39232131-287B18C0-0853-4BF2-BA59-8118FC7D3C40Q40298171-24278A0A-1759-45F8-B0F0-3A3BE5D35332Q40590985-4AA96010-3301-4C94-AE77-A38350D285CAQ41706567-CCBD7C7B-B8A9-4D1D-BB0E-A6D54F069A0AQ47567474-98756723-DF88-4447-903B-C9234F344A16Q48067085-63307A21-FE6D-4ECB-A227-97AAE3403F01
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Oral effects of low-dose methotrexate treatment.
@ast
Oral effects of low-dose methotrexate treatment.
@en
type
label
Oral effects of low-dose methotrexate treatment.
@ast
Oral effects of low-dose methotrexate treatment.
@en
prefLabel
Oral effects of low-dose methotrexate treatment.
@ast
Oral effects of low-dose methotrexate treatment.
@en
P2093
P1476
Oral effects of low-dose methotrexate treatment.
@en
P2093
Athanasios Kalantzis
Denis T Falconer
Edward W Odell
Peter R Morgan
Zoe Marshman
P356
10.1016/J.TRIPLEO.2004.08.020
P577
2005-07-01T00:00:00Z